CA
NZ
UK
AU
IND
US
Novartis (Basel) stands at a key moment as three key drug studies approach their readouts later this year. The programs, one targeting a cardiovascular condition, another addressing multiple sclerosis, and a third focused on a rare genetic disorder, have the collective potential to generate …
Karyopharm Therapeutics Inc. (NASDAQ: KPTI) has announced a retention program targeting its senior leadership team, including the Chief Executive Officer, as the company prepares for a series of strategic developments. The program is structured to reinforce leadership continuity during a period of anticipated catalysts …
NanoViricides has established a flexible financing mechanism through an at-market stock sales agreement, enabling the company to issue shares as needed. The arrangement, finalized with D. Boral Capital LLC, allows the antiviral drug developer to access capital markets without the constraints of a fixed …
JPMorgan Chase Financial Company LLC priced $368 million in structured notes on July 16, 2026, designed to provide leveraged exposure to the performance of the iShares MSCI EAFE ETF and the EURO STOXX 50 Index. The notes, fully guaranteed by JPMorgan Chase & Co., …
The settlement, disclosed in a regulatory filing, closes a probe by the U.S. Department of Justice and the Office of Inspector General without the company admitting wrongdoing. EyePoint will also enter a Corporate Integrity Agreement with the Department of Health and Human Services, mandating …
Hims & Hers Health has announced the resignation of its Chief Accounting Officer, the latest in a series of leadership changes at the telehealth provider. The departure follows a series of similar disclosures and comes as the company navigates a period of steady but …
IBio has announced that its upcoming annual shareholder gathering will take place in mid‑October, prompting a revision of the deadlines for shareholder proposals as the company’s shares continue to face downward pressure. The meeting will be held on a date set for the middle …
An executive at Inspire Medical Systems sold shares last week, a move that has drawn attention to the accelerating demand for obstructive sleep apnea treatments. The transaction, disclosed in a regulatory filing, coincides with a broader uptick in investor interest in sleep apnea stocks, …
Intuitive Surgical’s stock retreated this week as investors weighed solid second‑quarter results against a tempered outlook for procedure growth. The robotic‑surgery leader reported a 16% year‑over‑year increase in worldwide procedures, driven by a 15% rise in da Vinci surgeries and a 36% surge in …
Tamari Shahar, Chief Operating Officer and Director of Global-E Online Ltd. (NASDAQ: GLBE), sold 24,999 ordinary shares on July 17, 2026, at an average price of $37.9815 per share, according to a statement of changes in beneficial ownership filed on July 20, 2026. The …
Please wait processing your request...